Cited by 77Pituitary Gland Disorders and TreatmentsSleep and Wakefulness ResearchCircadian rhythm and melatonin

Increased Daytime Sleepiness in Patients with Childhood Craniopharyngioma and Hypothalamic Tumor Involvement: Review of the Literature and Perspectives

Open access
Müller, Hermann L.·2010·International Journal of Endocrinology

Abstract

Childhood craniopharyngiomas are rare embryogenic malformations of the sellar region, presumably derived from Rathke cleft epithelium. The overall survival rates after neurosurgical intervention and/or irradiation are high (92%). However, the quality of survival is frequently impaired due to endocrine deficiencies, sleep disturbances, daytime sleepiness, and severe obesity caused by hypothalamic lesions. Based on self-assessment using nutritional diaries, caloric intake was similar in patients and BMI-matched controls. Analyses of physical activity by accelerometric measurements showed a markedly lower level of physical activity. Significant daytime sleepiness and disturbances of circadian rhythms have been demonstrated in obese childhood craniopharyngioma patients. Daytime sleepiness and obesity in these patients were both correlated with low nocturnal and early morning melatonin levels. Polysomnographic studies in patients with severe daytime sleepiness revealed sleeping patterns typical for secondary narcolepsy. Reports on a beneficial effect of treatment with central stimulating agents supported the hypothesis that secondary narcolepsy should be considered as a rare cause for severe daytime sleepiness in patients with childhood craniopharyngioma.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2010/519607

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Fatigue in individuals with hypothalamic syndrome could potentially be related to disordered signaling from GABAergic neurons in the suprachiasmatic, ventrolateral, and preoptic nuclei.

    “Commonly reported fatigue (72, 73) could potentially be related to disordered signaling from γ-aminobutyric acid (GABA)-ergic neurons in the suprachiasmatic, ventrolateral, and preoptic nuclei (74, 75).”

    From Approach to the patient with acquired hypothalamic syndrome (2026) · cites this paper as [73]

    The paper’s Abstract links hypothalamic injury, including possible suprachiasmatic nucleus dysfunction, to increased daytime sleepiness in patients with childhood craniopharyngioma. It does not attribute that symptom to disordered GABAergic signaling in the suprachiasmatic, ventrolateral, and preoptic nuclei; its discussion instead focuses on melatonin and orexin. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 57 · Cited by 77

Research works printed but not linked: 54

  1. [1]Einhaus SL Sanford RA Albright AL Pollack IF Adelson PD Craniopharyngiomas Principles and practice of Pediatric Neurosurgery 1999 New York, NY, USA Thieme 545 562
  2. [2]Bunin GR Surawicz TS Witman PA Preston-Martin S Davis F Bruner JM The descriptive epidemiology of craniopharyngioma Journal of Neurosurgery 1998 89 4 547 551 9761047
  3. [3]Müller-Scholden J Lehrnbecher T Müller HL Radical surgery in a neonate with craniopharyngioma: report of a case Pediatric Neurosurgery 2000 33 5 265 269 11155065
  4. [4]Rolland-Cachera MF Cole TJ Sempe M Tichet J Rossignol C Charraud A Body mass index variations: centiles from birth to 87 years European Journal of Clinical Nutrition 1991 45 1 13 21 1855495
  5. [5]Müller HL Handwerker G Wollny B Faldum A Sörensen N Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients Journal of Clinical Endocrinology and Metabolism 2002 87 8 3993 3996 12161549
  6. [6]Warmuth-Metz M Gnekow AK Müller H Solymosi L Differential diagnosis of suprasellar tumors in children Klinische Padiatrie 2004 216 6 323 330 15565547
  7. [7]Müller HL Gebhardt U Schröder S Analyses of treatment variables for patients with childhood craniopharyngioma—results of the ulticenter prospective trial KRANIOPHARYNGEOM 2000 after three years of follow-up Hormone Research in Paediatrics 2010 73 3 175 180 20197669
  8. [8]Müller HL Childhood craniopharyngioma: recent advances in diagnosis, treatment and follow-up Hormone Research 2008 69 4 193 202 18204266
  9. [9]Müller HL Bueb K Bartels U Obesity after childhood craniopharyngioma—German multicenter study on pre-operative risk factors and quality of life Klinische Padiatrie 2001 213 4 244 249 11528558
  10. [10]Müller HL Gebhardt U Pohl F High rates of early relapses after complete resection and early progressions after incomplete resection of childhood craniopharyngioma-update on KRANIOPHARYNGEOM 2000 and design of KRANIOPHARYNGEOM 2007 Klinische Padiatrie 2006 218 6 315 320 17080333
  11. [11]Becker G Kortmann RD Skalej M Bamberg M Wiegel T Hinkelbein T Brock M Hoell T The role of radiotherapy in the treatment of craniopharyngeoma – indications, results, side effects Controversies in Neuro-Oncology 1999 33 Basel, witzerland Karger 100 113 Frontiers of Radiation Therapy and Oncology 10549481
  12. [12]Müller HL More or less? Treatment strategies in childhood craniopharyngioma Child’s Nervous System 2006 22 2 156 157 16320024
  13. [13]Müller HL Albanese A Calaminus G Consensus and perspectives on treatment strategies in children craniopharyngioma: results of a meeting of the Craniopharyngioma Study Group (SIOP), Genova, 2004 Journal of Pediatric Endocrinology and Metabolism 2006 19 1 453 454 16700324
  14. [14]Müller HL Bruhnken G Emser A Longitudinal study on quality of life in 102 survivors of childhood craniopharyngioma Child’s Nervous System 2005 21 11 975 980 16075216
  15. [15]Müller HL Emser A Faldum A Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma Journal of Clinical Endocrinology and Metabolism 2004 89 7 3298 3305 15240606
  16. [16]Müller HL Gebhardt U Etavard-Gorris N Prognosis and sequela in patients with childhood craniopharyngioma - Results of HIT-ENDO and update on KRANIOPHARYN-GEOM 2000 Klinische Padiatrie 2004 216 6 343 348 15565549
  17. [17]Müller HL Faldum A Etavard-Gorris N Functional capacity, obesity and hypothalamic involvement: cross-sectional study on 212 patients with childhood craniopharyngioma Klinische Padiatrie 2003 215 6 310 314 14677094
  18. [18]Müller HL Gebhardt U Etavard-Gorris N Kolb R Warmuth-Metz M Sorensen N Current strategies in diagnostics and endocrine treatment of patients with childhood craniopharyngioma during follow-up—recommendations in KRANIOPHARYNGEOM 2000 Onkologie 2005 28 3 150 156 15772466
  19. [19]Müller HL Gebhardt U Faldum A Functional capacity and body mass index in patients with sellar masses—cross-sectional study on 403 patients diagnosed during childhood and adolescence Child’s Nervous System 2005 21 7 539 545 15889310
  20. [20]Müller HL Handwerker G Gebhardt U Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness Cancer Causes and Control 2006 17 4 583 589 16596314
  21. [21]Müller HL Heinrich M Bueb K Perioperative dexamethasone treatment in childhood craniopharyngioma—influence on short-term and long-term weight gain Experimental and Clinical Endocrinology and Diabetes 2003 111 6 330 334 14520598
  22. [22]Müller HL Müller-Stöver S Gebhardt U Kolb R Sörensen N Handwerker G Secondary narcolepsy may be an underrated cause of increased daytime sleepiness in obese patients after childhood craniopharyngioma Journal of Pediatric Endocrinology & Metabolism 2006 19 423 429 16700320
  23. [23]Müller HL Schneider P Bueb K Volumetric bone mineral density in patients with childhood craniopharyngioma Experimental and Clinical Endocrinology and Diabetes 2003 111 3 168 173 12784191
  24. [24]Roth CL Gebhardt U Müller HL Appetite-regulating hormone changes in patients with craniopharyngioma Obesity. In press 20379145
  25. [26]Bloch KE Schoch OD Zhang JN Russi EW German version of the Epworth Sleepiness Scale Respiration 1999 66 5 440 447 10516541
  26. [27]Brzezinski A Melatonin in humans New England Journal of Medicine 1997 336 3 186 195 8988899
  27. [28]Flynn FG Cummings JL Tomiyasu U Altered behavior associated with damage to the ventromedial hypothalamus: a distinctive syndrom Behavioral Neurology 1988 49 58 24486901
  28. [29]Laakso M-L Porkka-Heiskanen T Alila A Stenberg D Johansson G Correlation between salivary and serum melatonin: dependence on serum melatonin levels Journal of Pineal Research 1990 9 1 39 50 2231272
  29. [30]Vaughan GM New sensitive serum melatonin radioimmunoassay employing the Kennaway G280 antibody: Syrian hamster morning adrenergic response Journal of Pineal Research 1993 15 2 88 103 8283389
  30. [31]Murata J-I Sawamura Y Ikeda J Hashimoto S Honma K-I Twenty-four hour of melatonin in patients with a history of pineal and/or hypothalamo-neurohypophyseal germinoma Journal of Pineal Research 1998 25 3 159 166 9745984
  31. [32]Ostrowska Z Buntner B Banas I Kos-Kudla B Marek B Zwirska-Korczala K Circadian variations of salivary melatonin levels in women of reproductive and postmenopausal age with gynoid and android obesity Endocrine Regulations 1996 30 3 143 152 10979045
  32. [33]Tamarkin L Abastillas P Chen HC Sidbury A Sidbury JB The daily profile of plasma melatonin in obese and Prader-Willi syndrome children Journal of Clinical Endocrinology and Metabolism 1982 55 3 491 495 7096537
  33. [34]Birketvedt GS Florholmen J Sundsfjord J Behavioral and neuroendocrine characteristics of the night-eating syndrome Journal of the American Medical Association 1999 282 7 657 663 10517719
  34. [35]Waldhauser F Ehrhart B Forster E Clinical aspects of the melatonin action: impact of development, aging, and puberty Experientia 1993 49 8 671 681 8359273
  35. [36]Müller HL Childhood craniopharyngioma—current controversies on management in diagnostics, teratment and follow-up Expert Review of Neurotherapeutics 2010 10 4 515 524 20367205
  36. [37]Lin L Faraco J Li R The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene Cell 1999 98 3 365 376 10458611
  37. [38]Chemelli RM Willie JT Sinton CM Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation Cell 1999 98 4 437 451 10481909
  38. [39]Wagner D Salin-Pascual R Greco MA Shiromani PJ Distribution of hypocretin-containing neurons in the lateral hypothalamus and c-Fos-immunoreactive neurons in the VLPO Sleep Research Online 2000 3 1 35 42 11382898
  39. [40]Nishino S Ripley B Overeem S Lammers GJ Mignot E Hypocretin (orexin) deficiency in human narcolepsy Lancet 2000 355 9197 39 40 10615891
  40. [41]Peyron C Faraco J Rogers W A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains Nature Medicine 2000 6 9 991 997 10973318
  41. [42]Thannickal TC Moore RY Nienhuis R Reduced number of hypocretin neurons in human narcolepsy Neuron 2000 27 3 469 474 11055430 PMC8760623
  42. [43]John J Wu M-F Siegel JM> Systemic administration of hypocretin-1 reduces cataplexy and normalizes sleep and waking durations in narcoleptic dogs Sleep Research Online 2002 3 1 2823 2825 PMC8846547 11382896
  43. [44]Marcus CL Trescher WH Halbower AC Lutz J Secondary narcolepsy in children with brain tumors Sleep 2002 25 4 435 439 12071545
  44. [46]García-Borreguero D Wehr TA Larrosa O Glucocorticoid replacement is permissive for rapid eye movement sleep and sleep consolidation in patients with adrenal insufficiency Journal of Clinical Endocrinology and Metabolism 2000 85 11 4201 4206 11095454
  45. [47]Krahn LE Boeve BF Oliver L Silber MH Hypocretin (orexin) and melatonin values in a narcoleptic-like sleep disorder after pinealectomy Sleep Medicine 2002 3 6 521 523 14592149
  46. [48]Marcus CL Trescher WH Halbower AC Lutz J Secondary narcolepsy in children with brain tumors Sleep 2002 25 4 435 439 12071545
  47. [49]Anderson M Salmon MV Symptomatic cataplexy Journal of Neurology Neurosurgery and Psychiatry 1977 40 2 186 191 PMC492636 864483
  48. [50]D’Cruz OF Vaughn BV Gold SH Greenwood RS Symptomatic cataplexy in pontomedullary lesions Neurology 1994 44 11 2189 2191 7969983
  49. [51]Stahl SM Layzer RB Aminoff MJ Continuous cataplexy in a patient with a midbrain tumor: the limp man syndrome Neurology 1980 30 10 1115 1118 6252510
  50. [52]Ethelberg S On cataplexy in a case of frontal lobe tumour Acta Psychiatrica et Neurologica 1949 24 3-4 421 427 15390913
  51. [53]Smith T Cataplexy in association with meningeomas Acta Neurologica Scandinavica. Supplementum 1983 67 94 45 47 6410675
  52. [54]Minami S Asai M Iwahori K Utsumi T Kido T Kiyoshi K Three cases of metastatic meningeal carcinomatosis from lung cancer Nihon Kokyuki Gakkai Zasshi 2002 40 6 513 519 12325339
  53. [55]Mason PW Krawiecki N Meacham LR The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma Archives of Pediatrics and Adolescent Medicine 2002 156 9 887 892 12197795
  54. [57]Müller HL Craniopharyngioma—current concepts in diagnosis, therapy and follow-up Nature Review Endocrinology 2010 6 11 609 618 20877295

Authors
Müller, H. L.
Affiliations
Department of Paediatrics and Paediatric Hematology and Oncology, Klinikum Oldenburg, Rahel-Straus-Straße 10, 26133 Oldenburg, Germany
Venue
International Journal of Endocrinology
Publisher
Wiley
Published
2010
Volume
2010
Pages
1-7
ISSN
  • 1687-8337 (ISSN-L)
  • 1687-8345
OpenAlex
W2083867031
Cited by
77
References
57
Citations by year
2026: 4 · 2025: 7 · 2024: 4 · 2023: 6 · 2022: 9 · 2021: 5 · 2020: 6 · 2019: 5 · 2018: 5 · 2017: 5 · 2016: 4 · 2015: 4 · 2014: 8 · 2012: 4
FWCI
1.21
Type
journal article
Language
en
Open access
Locations
  • International Journal of Endocrinology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
Deutsche Kinderkrebsstiftung
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
Keywords
childhood craniopharyngioma, hypothalamic tumors, daytime sleepiness, hypothalamic obesity, circadian rhythm disruption, melatonin, physical activity, sleep-disordered breathing, endocrine insufficiency

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review